微信内可能无法直接打开本站。请点右上角 ··· → 在浏览器打开，或复制链接。
STAT+: Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder
RSS 官方收录 · 可信分层展示
关键摘要
Ionis Pharmaceuticals on Thursday received Food and Drug Administration approval for the first disease modifying therapy for Alexander disease, a rare and deadly neurological condition.…
- The FDA approved the drug, Zanvastro, for use in children and adults a…
- The study also contained hints that treating young children can improv…
- Researchers found that the drug was generally safe, with serious adver…
摘要引擎：抽取
正文提要
Ionis Pharmaceuticals on Thursday received Food and Drug Administration approval for the first disease modifying therapy for Alexander disease, a rare and deadly neurological condition.
The FDA approved the drug, Zanvastro, for use in children and adults after a pivotal trial showed that walking speed, a common measure of motor function in neurologic disease, stayed stable in treated patients while those in the control group saw a 33% decline.
The study also contained hints that treating young children can improve motor function, not just stabilize it. Researchers found that the drug was generally safe, with serious adverse events more common in the control group than among those treated.